Microbiome in multiple sclerosis: Where are we, what we know and do not know

MK Boziki, E Kesidou, P Theotokis, AFA Mentis… - Brain sciences, 2020 - mdpi.com
An increase of multiple sclerosis (MS) incidence has been reported during the last decade,
and this may be connected to environmental factors. This review article aims to encapsulate …

Recent advances in antigen-specific immunotherapies for the treatment of multiple sclerosis

O Kammona, C Kiparissides - Brain Sciences, 2020 - mdpi.com
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system and is
considered to be the leading non-traumatic cause of neurological disability in young adults …

Kappa free light chains and IgG combined in a novel algorithm for the detection of multiple sclerosis

M Gudowska-Sawczuk, J Tarasiuk, A Kułakowska… - Brain sciences, 2020 - mdpi.com
Background: It is well known that the cerebrospinal fluid (CSF) concentrations of free light
chains (FLC) and immunoglobulin G (IgG) are elevated in multiple sclerosis patients (MS) …

Novel approaches in the immunotherapy of multiple sclerosis: Cyclization of myelin epitope peptides and conjugation with mannan

JM Matsoukas, I Ligielli, CT Chasapis, K Kelaidonis… - Brain sciences, 2021 - mdpi.com
Multiple Sclerosis (MS) is a serious autoimmune disease. The patient in an advanced state
of the disease has restrained mobility and remains handicapped. It is therefore …

Myelin Oligodendrocyte Glycoprotein (MOG) 35–55 Mannan Conjugate Induces Human T-Cell Tolerance and Can Be Used as a Personalized Therapy for Multiple …

M Rodi, AL de Lastic, I Panagoulias… - International Journal of …, 2024 - mdpi.com
We have previously performed preclinical studies with the oxidized mannan-conjugated
peptide MOG35–55 (OM-MOG35–55) in vivo (EAE mouse model) and in vitro (human …

The Long Road of Immunotherapeutics against Multiple Sclerosis

V Apostolopoulos, A Rostami, J Matsoukas - Brain Sciences, 2020 - mdpi.com
This commentary highlights novel immunomodulation and vaccine-based research against
multiple sclerosis (MS) and reveals the amazing story that triggered this cutting-edge MS …

Peptide-based vaccines and altered peptide ligands: Multiple sclerosis paving the way

N Zoupanou, N Georgiou, K Moschovou… - … for Infectious and …, 2024 - Elsevier
Multiple sclerosis is a well-characterized autoimmune disease with social consequences as
the patient usually remains handicapped and needs help from their family, helpers, nurses …

[HTML][HTML] Иммунологические факторы перинатального поражения нервной системы у детей, родившихся от матерей с нарушениями углеводного обмена

ДС Богомаз - Экспериментальная и клиническая …, 2022 - cyberleninka.ru
Беременность, протекающая на фоне сахарного диабета часто осложняется
фетоплацентарной недостаточностью, внутриутробной гипоксией, что оказывает …

ОСОБЕННОСТИ МОРФОФУНКЦИОНАЛЬНОГО И ИММУННОГО СТАТУСА ДЕТЕЙ, РОДИВШИХСЯ ОТ МАТЕРЕЙ С ГЕСТАЦИОННЫМ САХАРНЫМ …

ЛА Харитонова, ОВ Папышева… - Педиатрия. Журнал им …, 2020 - elibrary.ru
Беременность, протекающая на фоне сахарного диабета (СД), часто осложняется
развитием макросомии и внутриутробной асфиксии, что является одной из основных …